FIELD: medicine.
SUBSTANCE: proposed group of inventions relates to medicine. Proposed are a method and a set for diagnosing the molecular phenotype of patients suffering from a disease accompanied by chronic inflammation, and classified as "Th2-high", "Th2-low", "Th1-high" or "Th1-low". Proposed is a medication for the treatment of such patients, containing a DNA-enzyme specific for GATA-3 or Tbet.
EFFECT: proposed group of inventions provides effective methods for determining the molecular phenotype of a patient suffering from a disease accompanied by chronic inflammation, and medications that are effective for the identified subgroup of patients.
9 cl, 9 dwg, 1 tbl, 7 ex
Authors
Dates
2018-11-16—Published
2013-09-04—Filed